![](https://www.citeline.com/-/media/citeline/resources/2024/05/2024-pharma-rd-review/resource-hero.jpg?la=ja-JP&h=528&w=1340&hash=96DB155C29B9FD1A3D779C0869E0C228)
![](https://www.citeline.com/-/media/citeline/resources/2024/05/2024-pharma-rd-review/resource-hero.jpg?la=ja-JP&h=528&w=1340&hash=96DB155C29B9FD1A3D779C0869E0C228)
Join the team at Citeline for an exclusive preview of its long-running Pharma R&D Annual Review. Pharmaprojects’ annual review of trends in pharmaceutical R&D takes the temperature of the industry at the start of 2024 by assessing the pipeline by company, therapeutic area, disease, target, and emerging drug modalities and regional variations.